홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

베라파밀 하이드로클로라이드

Verapamil Hydrochloride

HCID 62969
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
152-11-4
표준 SMILES
COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC.Cl
InChIKey
DOQPXTMNIUCOSY-UHFFFAOYSA-N
분자식
C27H39ClN2O4
평균 분자량
491.1 g/mol
단동위원소 질량
490.2598354

개요

Verapamil Hydrochloride is the hydrochloride form of Verapamil, which is a phenylalkylamine calcium channel blocking agent. Verapamil inhibits the transmembrane influx of extracellular calcium ions into myocardial and vascular smooth muscle cells, causing dilatation of the main coronary and systemic arteries and decreasing myocardial contractility. This agent also inhibits the drug efflux pump P-glycoprotein which is overexpressed in some multi-drug resistant tumors and may improve the efficacy of some antineoplastic agents. (NCI04)

이름 및 식별자

우선 이름
Verapamil Hydrochloride
IUPAC
2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile;hydrochloride
현지명
베라파밀 하이드로클로라이드
영어명
(+/-)-Verapamil hydrochloride
분자식
C27H39ClN2O4
분자량
491.06

이름 및 동의어

Verapamil hydrochloride152-11-4Verapamil HClVerelanCoveraIsoptin SRVerelan PMCalan SRVerapamili hydrochloridumDTXSID2034095Securon midManidon sr
이름 더 보기
베라파밀 하이드로클로라이드(+/-)-베라파밀염산염manidoncordiloxizoptinhydrochloridelu20175RositolfinoptinHormitolMagotironVerapamil HCId-365hydrochloride
Ranvera mrNSC-272366NSC-657799V3888OEY5RNSC657799LU-20175(+-)-Verapamil hydrochlorideDTXCID0014095

데이터베이스 식별자

CAS
152-11-4、23313-68-0
PubChem CID
62969
DTXSID
DTXSID2034095
ChEMBL
CHEMBL1280
UNII
V3888OEY5R
EC Number
205-800-5、245-579-2、862-789-5

물성

구조 계산 물성

극성 표면적
64 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
6
회전 가능 결합 수
13
무거운 원자 수
34
형식 전하
0
복잡도
606

실험 및 물리화학적 성질

Human Drugs · 2건

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section208.9 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
142 °C · 142 °C (dec.)(lit.)
밀도
1.0596 · 1.0596 (rough estimate)
굴절률
1.629 · 1.6290 (estimate)
인화점
9 ℃ · 9℃
저장 조건
2 · 2-8°C
용해도
2 O: · H2O: >30 mg/mL
산도 계수 (pKa)
8.6 · 8.6(at 25℃)
물리적 상태
고체
색상
하얀색
수용성
녹는
Merck
14 · 14,9950
BRN
3647093 · 3647093
BCS Class
2 · 2
안정성
2 · 제공된 대로 구매일로부터 2년 동안 안정적입니다. DMSO 또는 증류수에 용해된 용액은 -20°C에서 최대 3개월 동안 보관할 수 있습니다.
InChI

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 6건

Danger

H301+H311 (10.4%): Toxic if swallowed or in contact with skin [Danger Acute toxicity, oral; acute toxicity, dermal]

P260, P261, P262, P264, P264+P265, P270, P271, P273, P280, P284, P301+P316, P301+P317, P302+P352, P304+P340, P305+P351+P338, P316, P319, P320, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 270 reports by companies from 15 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

유해성 정보

Regulatory InformationVerapamil hydrochloride: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - Benzeneacetonitrile, .alpha.-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-.alpha.-(1-methylethyl)-, monohydrochloride: Human health tier I assessment
Hazard Classes and CategoriesAcute Tox. 3 (99.6%)

독성 정보

Treatment · 1건

Treatment of overdosage should be supportive. Beta-adrenergic stimulation or parenteral administration of calcium solutions may increase calcium ion flux across the slow channel and have been used effectively in treatment of deliberate overdosage with verapamil. In a few reported cases, overdose with calcium channel blockers has been associated with hypotension and bradycardia, initially refractory to atropine but becoming more responsive to this treatment when the patients received large doses (close to 1 gram/hour for more than 24 hours) of calcium chloride. Verapamil cannot be removed by hemodialysis. Clinically significant hypotensive reactions or high degree AV block should be treated with vasopressor agents or cardiac pacing, respectively. Asystole should be handled by the usual measures including cardiopulmonary resuscitation. (L1712)

화학 및 산업

약리 정보

Metabolism/MetabolitesRoute of Elimination: Approximately 70% of an administered dose is excreted as metabolites in the urine and 16% or more in the feces within 5 days. About 3% to 4% is excreted in the urine as unchanged drug. Half Life: 2.8-7.4 hours
FDA Pharmacological Classification · 4건

VERAPAMIL HCI

Calcium Channel Blocker [EPC]; Calcium Channel Antagonists [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

VERAPAMIL HYDROCHLORIDE

Calcium Channel Blocker [EPC]; Calcium Channel Antagonists [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

MeSH Pharmacological Classification · 3건

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

A class of drugs that act by selective inhibition of calcium influx through cellular membranes.

Drugs used to cause dilation of the blood vessels.

용도 및 제조

UsesDrug used for the treatment of hypertension, angina, and cluster headache prophylaxis.
응용 분야 · 2건

용도analgesic, antipyretic

일반 설명Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Verapamil hydrochloride is a calcium channel blocker used commonly for the management of angina, supra-ventricular tachyarrhythmia, hypertension, migraine and atrial tachyarrhythmias.

관련 반응

5건
반응 기록 만들기
HRID 324915 반응식
HRID 324915반응물로
HRID 1249656 반응식
HRID 1249656반응물로
HRID 1408273 반응식
HRID 1408273반응물로
HRID 1456876 반응식
HRID 1456876반응물로
HRID 2414989 반응식
HRID 2414989반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
1S/C27H38N2O4.ClH/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6;/h9-12,17-18,20H,8,13-16H2,1-7H3;1H
InChIKey
DOQPXTMNIUCOSY-UHFFFAOYSA-N
SMILES
Cl.COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC

화학적 성질

white to off-white powder

Health Effects · 1건

Cardiovascular: angina pectoris, AV block (2° & 3°), atrioventricular dissociation, CHF, pulmonary edema, chest pain, claudication, myocardial infarction, palpitations, purpura (vasculitis), syncope. Digestive system: diarrhea, dry mouth, gastrointestinal distress, gingival hyperplasia. Hemic and lymphatic: ecchymosis or bruising. Nervous system: cerebrovascular accident, confusion, equilibrium disorders, insomnia, muscle cramps, psychotic symptoms, shakiness, somnolence, extrapyramidal symptoms. Skin: arthralgia and rash, exanthema, hair loss, hyperkeratosis, macules, sweating, urticaria, Stevens-Johnson syndrome, erythema multiforme. Special senses: blurred vision, tinnitus. Urogenital: gynecomastia, galactorrhea/hyperprolactinemia, increased urination, spotty menstruation, impotence.

Exposure RoutesOrally, 90‰ЫТ100% of Verapamil is absorbed. Intravenous.
Toxicity Summary · 1건

Verapamil inhibits voltage-dependent calcium channels. Specifically, its effect on L-type calcium channels in the heart causes a reduction in ionotropy and chronotropy, thuis reducing heart rate and blood pressure. Verapamil's mechanism of effect in cluster headache is thought to be linked to its calcium-channel blocker effect, but which channel subtypes are involved is presently not known.

Signs and Symptoms · 1건

The resultant inhibition of the contractile processes of the myocardial smooth muscle cells leads to dilation of the coronary and systemic arteries,improved oxygen delivery to the myocardial tissue, and decreased total peripheral resistance, systemic blood pressure, and afterload.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6건

Drug Induced Liver Injury Rank (DILIrank 2.0)

Verapamil hydrochloride

vLess-DILI-concern

3

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

Toxicity DataLD50: 8 mg/kg (Intravenous, Mouse) (A308)

안전 데이터

wgk
3
rtecs
YV8320000
ridadr
UN 2811 6.1/PG 3
독성
LD50 in mice, rats (mg/kg): 7.6, 16 i.v.; 68, 107 s.c.; 68, 67 i.p.; 163, 114 orally (Haas, Hrtfelder)
HS 번호
29269090
risk_code
25-23/24/25-39/23/24/25-11
hazard_code
T,F
safety_code
45-36/37/39-36/37-16
포장분류
III
위험 등급
6.1(b)
F 고인화성물질
8-10
Hazard Classifications
Acute Tox. 3 OralAquatic Chronic 2
스토리지 클래스
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects

제조 방법

염화 베라트릴(Veratryl chloride) + 아이소프로필 브로마이드(isopropyl bromide) + 호모베라트릴아민(homoveratrylamine) + 1-브로모-3-클로로포페인 (디하이드로브로미네이션(dehydrobromination)/메틸화(methylation)/아민형성(amine formation)/디하드로클로리네이션(dehydrochlorination))

상·하류 제품 정보

상류 원료

3,4-디메톡시페닐아세토니트릴이소프로필브로마이드과이아콜